These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25932808)

  • 41. [A late formed diagnosis!].
    Thijssen-Bos F; Slee PH
    Ned Tijdschr Geneeskd; 1988 Nov; 132(48):2185-7. PubMed ID: 2849721
    [No Abstract]   [Full Text] [Related]  

  • 42. Fabry disease: enzymatic diagnosis in dried blood spots on filter paper.
    Chamoles NA; Blanco M; Gaggioli D
    Clin Chim Acta; 2001 Jun; 308(1-2):195-6. PubMed ID: 11432396
    [No Abstract]   [Full Text] [Related]  

  • 43. Enhanced filter paper enzyme assay for high-throughput population screening for Fabry disease.
    Poeppl AG; Murray GJ; Medin JA
    Anal Biochem; 2005 Feb; 337(1):161-3. PubMed ID: 15649390
    [No Abstract]   [Full Text] [Related]  

  • 44. Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy.
    Thurberg BL; Fallon JT; Mitchell R; Aretz T; Gordon RE; O'Callaghan MW
    Circulation; 2009 May; 119(19):2561-7. PubMed ID: 19414635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical and pathological aspects of angiokeratoma corporis diffusum Fabry. Report of a case].
    Knopf B; Roth J
    Dermatol Monatsschr; 1973 Dec; 159(12):1105-13. PubMed ID: 4210191
    [No Abstract]   [Full Text] [Related]  

  • 46. Atypical Fabry's disease. An oligosymptomatic variant.
    Ko YH; Kim HJ; Roh YS; Park CK; Kwon CK; Park MH
    Arch Pathol Lab Med; 1996 Jan; 120(1):86-9. PubMed ID: 8554452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testing the feasibility of fully automated chip-based nanoelectrospray ionization mass spectrometry as a novel tool for rapid diagnosis of Fabry disease.
    Flangea C; Mosoarca C; Cozma C; Galusca M; Przybylski M; Zamfir AD
    Electrophoresis; 2013 Jun; 34(11):1572-80. PubMed ID: 23483567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease.
    Smid BE; van der Tol L; Biegstraaten M; Linthorst GE; Hollak CE; Poorthuis BJ
    J Med Genet; 2015 Apr; 52(4):262-8. PubMed ID: 25596309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Fabry disease: clinical, biochemical and electron microscopical studies (author's transl)].
    Klug H; Zabel R; Evers U
    Dermatol Monatsschr; 1979 Jan; 165(1):46-54. PubMed ID: 220105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormonal profile and fertility in patients with Anderson-Fabry disease.
    Hauser AC; Gessl A; Harm F; Wiesholzer M; Kleinert J; Wallner M; Voigtländer T; Bieglmayer C; Sunder-Plassmann G
    Int J Clin Pract; 2005 Sep; 59(9):1025-8. PubMed ID: 16115176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fabry disease in patients with end-stage renal failure: the potential benefits of screening.
    Bekri S; Enica A; Ghafari T; Plaza G; Champenois I; Choukroun G; Unwin R; Jaeger P
    Nephron Clin Pract; 2005; 101(1):c33-8. PubMed ID: 15886492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of recombinant alpha-galactosidase A therapy for amelioration of the cardiovascular manifestations of Fabry disease: an important role for endomyocardial biopsy.
    Buja LM
    Circulation; 2009 May; 119(19):2539-41. PubMed ID: 19451361
    [No Abstract]   [Full Text] [Related]  

  • 53. Plasma globotriaosylsphingosine as a biomarker of Fabry disease.
    Togawa T; Kodama T; Suzuki T; Sugawara K; Tsukimura T; Ohashi T; Ishige N; Suzuki K; Kitagawa T; Sakuraba H
    Mol Genet Metab; 2010 Jul; 100(3):257-61. PubMed ID: 20409739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Linkage relationship of the loci for Anderson--Fabry disease and the Xg blood groups.
    Johnston AW; Sanger R
    Ann Hum Genet; 1981 May; 45(2):155-7. PubMed ID: 6274251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Fabry's disease. Presentation of a case].
    Anasagasti I; Yerobi JA; Amato E; Poza J
    Rev Clin Esp; 1988 Mar; 182(4):236. PubMed ID: 2842825
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease.
    Colomba P; Nucera A; Zizzo C; Albeggiani G; Francofonte D; Iemolo F; Tuttolomondo A; Pinto A; Duro G
    Clin Biochem; 2012 Jul; 45(10-11):839-41. PubMed ID: 22465271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal transplantation in Anderson-Fabry disease.
    Clement M; McGonigle RJ; Monkhouse PM; Keogh AM; Marten RH; Bewick M; Parsons V
    J R Soc Med; 1982 Jul; 75(7):557-60. PubMed ID: 6283080
    [No Abstract]   [Full Text] [Related]  

  • 58. Detection of Anderson-Fabry cardiomyopathy with CMR in a patient with chest pain and elevated cardiac biomarkers.
    Albin G; Ryan M; Heltne C
    J Cardiovasc Magn Reson; 2006; 8(2):399-404. PubMed ID: 16669184
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A unique case of extensive myocardial late iodine enhancement on CT in Anderson-Fabry disease.
    Marek J; Bayerová K; Kuchynka P; Černý V; Linhart A
    Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):e63. PubMed ID: 36691823
    [No Abstract]   [Full Text] [Related]  

  • 60. Fabry disease: patients at risk in Brazil!
    Abensur H
    J Bras Nefrol; 2021; 43(1):5-6. PubMed ID: 33570082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.